Home › Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...
 

Keywords :   


Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...

2013-01-25 02:36:38| Biotech - Topix.net

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials evaluating a single tablet regimen containing tenofovir alafenamide for the treatment of HIV-1 infection in treatment-nai 1 2ve adults.

Tags: program phase clinical initiates

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11171
15.11 3FLYOVER
15.11 PSA8 - 1ed
15.11DMC RAVEN 18g
15.11LOVE or DEAD Blu-ray
15.11 HSGI SURE-GRIP PADDED BELT a-tacs au
15.11 BOUNTY HUNTER
15.11
More »